Cambridge Investment Research Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-28,450
| Closed | -$686K | – | 3338 |
|
|
2023
Q1 | $686K | Sell |
28,450
-1,445
| -5% | -$34.8K | ﹤0.01% | 1858 |
|
|
2022
Q4 | $316K | Buy |
29,895
+13,900
| +87% | +$147K | ﹤0.01% | 2392 |
|
|
2022
Q3 | $72K | Hold |
15,995
| – | – | ﹤0.01% | 2908 |
|
|
2022
Q2 | $64K | Hold |
15,995
| – | – | ﹤0.01% | 2924 |
|
|
2022
Q1 | $117K | Sell |
15,995
-400
| -2% | -$2.93K | ﹤0.01% | 2996 |
|
|
2021
Q4 | $92K | Sell |
16,395
-3,100
| -16% | -$17.4K | ﹤0.01% | 3041 |
|
|
2021
Q3 | $125K | Buy |
19,495
+3,100
| +19% | +$19.9K | ﹤0.01% | 2917 |
|
|
2021
Q2 | $138K | Sell |
16,395
-1,800
| -10% | -$15.2K | ﹤0.01% | 2916 |
|
|
2021
Q1 | $191K | Buy |
18,195
+3,195
| +21% | +$33.5K | ﹤0.01% | 2643 |
|
|
2020
Q4 | $254K | Buy |
15,000
+400
| +3% | +$6.77K | ﹤0.01% | 2277 |
|
|
2020
Q3 | $187K | Sell |
14,600
-500
| -3% | -$6.4K | ﹤0.01% | 2263 |
|
|
2020
Q2 | $213K | Buy |
+15,100
| New | +$213K | ﹤0.01% | 2134 |
|